These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29407093)

  • 1. Evolution of natriuretic peptide biomarkers in heart failure: Implications for clinical care and clinical trials.
    Vodovar N; Mebazaa A; Januzzi JL; Murtagh G; Stough WG; Adams KF; Zannad F
    Int J Cardiol; 2018 Mar; 254():215-221. PubMed ID: 29407093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction: A feasible surrogate trial endpoint? A report from the prospective Karen study.
    Savarese G; Donal E; Hage C; Oger E; Persson H; Daubert JC; Linde C; Lund LH;
    Int J Cardiol; 2017 Jan; 226():65-70. PubMed ID: 27788392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of natriuretic peptides at the point of care in the emergency and ambulatory setting: current status and future perspectives.
    Bingisser R; Cairns CB; Christ M; Collinson P; Hausfater P; Lindahl B; Mair J; Price C; Venge P
    Am Heart J; 2013 Oct; 166(4):614-621.e1. PubMed ID: 24093839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natriuretic peptides as biomarkers in heart failure.
    Januzzi JL
    J Investig Med; 2013 Aug; 61(6):950-5. PubMed ID: 23661103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Applications of Natriuretic Peptides in Heart Failure and Atrial Fibrillation.
    Baba M; Yoshida K; Ieda M
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31185605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Test in Context: Critical Evaluation of Natriuretic Peptide Testing in Heart Failure.
    Francis GS; Felker GM; Tang WH
    J Am Coll Cardiol; 2016 Jan; 67(3):330-7. PubMed ID: 26796399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypervolemic and optivolemic natriuretic peptides in acute heart failure.
    Xue Y; Taub PR; Fard A; Maisel AS
    Contrib Nephrol; 2011; 171():74-79. PubMed ID: 21625093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.
    Green SM; Green JA; Januzzi JL
    Am J Ther; 2009; 16(2):171-7. PubMed ID: 19300043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential role of natriuretic peptide-guided management for patients hospitalized for heart failure.
    Maisel A; Xue Y; Greene SJ; Pang PS; Januzzi JL; Piña IL; DeFilippi C; Butler J
    J Card Fail; 2015 Mar; 21(3):233-9. PubMed ID: 25433362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A national campaign for the promotion of the appropriate use of natriuretic peptide assays in heart failure patients].
    Di Lenarda A
    G Ital Cardiol (Rome); 2016 Jan; 17(1):48-50. PubMed ID: 26901258
    [No Abstract]   [Full Text] [Related]  

  • 11. Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: new challenges and perspectives.
    Clerico A; Passino C; Franzini M; Emdin M
    Future Cardiol; 2016 Sep; 12(5):573-84. PubMed ID: 27459871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sequential Natriuretic Peptide Measurements to Monitor Treatment and Prognosis During Heart Failure Therapy].
    Becher MU
    Dtsch Med Wochenschr; 2020 Apr; 145(7):458-463. PubMed ID: 32236926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical utility of natriuretic peptdies in dyspnea].
    Müller C
    Ther Umsch; 2009 Sep; 66(9):649-52. PubMed ID: 19725009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natriuretic peptide-guided management in heart failure.
    Chioncel O; Collins SP; Greene SJ; Ambrosy AP; Vaduganathan M; Macarie C; Butler J; Gheorghiade M
    J Cardiovasc Med (Hagerstown); 2016 Aug; 17(8):556-68. PubMed ID: 27110656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating natriuretic peptide levels in acute heart failure.
    Maisel A
    Rev Cardiovasc Med; 2007; 8 Suppl 5():S13-21. PubMed ID: 18192949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natriuretic peptide and cardiovascular risk: is it about "U"?
    deFilippi CR; Seliger SL
    J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25999399
    [No Abstract]   [Full Text] [Related]  

  • 17. Natriuretic peptide-guided therapy: further research required for still-unresolved issues.
    De Vecchis R; Esposito C; Cantatrione S
    Herz; 2013 Sep; 38(6):618-28. PubMed ID: 23588602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Measurement of natriuretic peptides in heart failure: the good laboratory and clinical practice].
    Kovács LG; Nyolczas N; Habon T; Sepp R; Piroth Z; Hajas Á; Boncz I; Tomcsányi J; Kappelmayer J; Merkely B
    Orv Hetil; 2015 Aug; 156(31):1235-45. PubMed ID: 26211747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impact of natriuretic peptides in current clinical practice].
    Ganovská E; Špinar J; Pařenica J
    Vnitr Lek; 2014; 60(5-6):474-83. PubMed ID: 24974752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natriuretic peptide testing in clinical medicine.
    Rehman SU; Januzzi JL
    Cardiol Rev; 2008; 16(5):240-9. PubMed ID: 18708825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.